When Academician Pan took out two application forms, Xu Yun and Zheng Zu quickly figured out the cause and effect:
Before today's three-party...or rather four-party meeting, Tian Liangwei and Academician Pan had already prepared everything!
The commercial prospect of the Fifth Generation Imidacloprid is indeed very alluring, but ultimately it's just a type of biopesticide, far from reaching the level of Lipitor, Ibuprofen, or the blue pill.
Therefore, having the Secretary of a fund like New Creation personally attend, is already quite a high specification.
Eight million cash flow plus attachments, accounting for 43%.
In other words, New Creation Fund values Xu Yun's company at around eighteen million.
New Creation Fund, being a tech innovation fund of a university, involves rather ambiguous specifics.
Generally, it's either VC or angel investment, occasionally Series A and rarely Series B.
